Emcure Pharmaceuticals Ltd (EMCURE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039308, "name": "Emcure Pharma", "stock_name": "Emcure Pharma", "full_name": "Emcure Pharmaceuticals Ltd", "name_url": "stocks-analysis/emcure-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,593.40", "chg": 53.7, "chgp": "3.49%", "dir": 1, "prev_price": "1,539.70", "mcapval": "29,747.00 Cr", "mcap": "Small Cap", "scripcode": 544210, "symbol": "EMCURE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE168P01015", "curr_date": "Mar 25", "curr_time": "", "bse_nse_vol": "5.46 lacs", "exc_status": "Active", "traded_date": "Mar 25, 2026", "traded_date_str": "2026 03 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emcure-pharma-10039308-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Emcure Pharmaceuticals Upgraded to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-upgraded-to-buy-on-strong-technical-and-financial-performance-3917704", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_mojoScore_3917704.png", "date": "2026-03-26 08:16:33", "description": "Emcure Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across technical indicators, financial performance, valuation metrics, and overall quality. This upgrade, effective from 25 March 2026, is underpinned by a robust technical trend, strong quarterly results, and favourable market returns that outpace benchmarks, signalling renewed investor confidence in the small-cap pharmaceutical firm." }, { "title": "Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1620", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1620-3916045", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_priceRelatedfactors_3916045.png", "date": "2026-03-25 10:50:36", "description": "With a decisive surge to Rs 1620 on 25 Mar 2026, Emcure Pharmaceuticals Ltd has reached a fresh 52-week high, extending its impressive 57.18% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market." }, { "title": "Emcure Pharmaceuticals Ltd Hits All-Time High of Rs 1,599.95 as Momentum Builds Across Timeframes", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-stock-hits-all-time-high-at-rs159995-3915972", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_priceRelatedfactors_3915972.png", "date": "2026-03-25 10:14:48", "description": "" }, { "title": "Emcure Pharmaceuticals Downgraded to Hold Amid Mixed Technical and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-3895974", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_mojoScore_3895974.png", "date": "2026-03-17 08:43:45", "description": "Emcure Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 16 March 2026, reflecting a nuanced assessment across quality, valuation, financial trends, and technical indicators. Despite strong financial performance and market-beating returns over the past year, evolving technical signals and valuation concerns have tempered enthusiasm among analysts." }, { "title": "Emcure Pharmaceuticals Gains 1.58%: 3 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-gains-158-3-key-factors-driving-the-weeks-momentum-3890509", "imagepath": "", "date": "2026-03-14 09:06:23", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 09:</strong> Intraday high surge to Rs.1,537 (+7.79%)</p>\n <p><strong>Mar 11:</strong> MarketsMOJO upgrades rating to Buy</p>\n <p><strong>Mar 13:</strong> Technical momentum shifts to mildly bullish</p>\n <p><strong>Mar 13:</strong> Week closes at Rs.1,437.20 (+1.58% weekly)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,414.80</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,437.20</div><div class=\"stat-change positiv..." }, { "title": "Emcure Pharmaceuticals Ltd: Technical Momentum Shifts Signal Mildly Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3888146", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_technicaldot_3888146.png", "date": "2026-03-13 08:02:59", "description": "Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early March 2026. Despite a recent day decline of 3.07%, the stock’s underlying technical indicators present a nuanced picture, reflecting both cautious optimism and emerging bearish signals. This analysis delves into the key technical parameters shaping Emcure’s near-term outlook, alongside its comparative market performance." }, { "title": "Emcure Pharmaceuticals Upgraded to Buy on Strong Financials and Market Outperformance", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-market-outperformance-3886369", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_mojoScore_3886369.png", "date": "2026-03-12 08:16:44", "description": "Emcure Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating by MarketsMOJO as of 11 March 2026, reflecting a marked improvement across key investment parameters including quality, valuation, financial trends, and technical indicators. This upgrade follows a series of robust quarterly performances and growing institutional interest, positioning the company favourably within the Pharmaceuticals & Biotechnology sector." }, { "title": "Emcure Pharmaceuticals Ltd Hits Intraday High with 7.79% Surge on 9 March 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-intraday-high-with-779-surge-on-9-march-2026-3880394", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_priceRelatedfactors_3880394.png", "date": "2026-03-09 14:04:54", "description": "Emcure Pharmaceuticals Ltd demonstrated a robust intraday performance on 9 Mar 2026, surging to an intraday high of Rs 1,537, marking an 8.64% increase from its previous close. The stock closed with a notable gain of 7.79%, significantly outperforming its sector and broader market indices amid a generally negative market environment." }, { "title": "Emcure Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-ltd-is-rated-hold-3864097", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EmcurePharmaceu_mojoScore_3864097.png", "date": "2026-03-02 10:10:36", "description": "Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 March 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook." } ], "total": 373, "sid": "10039308", "stock_news_url": "https://www.marketsmojo.com/news/emcure-pharmaceuticals-10039308" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Emcure Pharmaceuticals Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25", "dt": "2025-08-14", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 09: Intraday high surge to Rs.1,537 (+7.79%)

Mar 11: MarketsMOJO upgrades rating to Buy

Mar 13: Technical momentum shifts to mildly bullish

Mar 13: Week closes at Rs.1,437.20 (+1.58% weekly)

Read full news article

Emcure Pharmaceuticals Ltd: Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-03-13 08:02:59

Emcure Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early March 2026. Despite a recent day decline of 3.07%, the stock’s underlying technical indicators present a nuanced picture, reflecting both cautious optimism and emerging bearish signals. This analysis delves into the key technical parameters shaping Emcure’s near-term outlook, alongside its comparative market performance.

Read full news article

Emcure Pharmaceuticals Upgraded to Buy on Strong Financials and Market Outperformance

2026-03-12 08:16:44

Emcure Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating by MarketsMOJO as of 11 March 2026, reflecting a marked improvement across key investment parameters including quality, valuation, financial trends, and technical indicators. This upgrade follows a series of robust quarterly performances and growing institutional interest, positioning the company favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Emcure Pharmaceuticals Ltd Hits Intraday High with 7.79% Surge on 9 March 2026

2026-03-09 14:04:54

Emcure Pharmaceuticals Ltd demonstrated a robust intraday performance on 9 Mar 2026, surging to an intraday high of Rs 1,537, marking an 8.64% increase from its previous close. The stock closed with a notable gain of 7.79%, significantly outperforming its sector and broader market indices amid a generally negative market environment.

Read full news article

Emcure Pharmaceuticals Ltd is Rated Hold

2026-03-02 10:10:36

Emcure Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 March 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook.

Read full news article